Ioannidis J P, Galanos O, Katritsis D, Connery C P, Drossos G E, Swistel D G, Anagnostopoulos C E
Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.
J Am Coll Cardiol. 2001 Feb;37(2):521-8. doi: 10.1016/s0735-1097(00)01112-8.
We examined whether bilateral internal thoracic artery (BITA) revascularization is associated with any increased in-hospital mortality and complications compared with single internal thoracic artery (SITA) revascularization.
Despite proven long-term benefits, BITA revascularization has been slow to be adopted because of fear of increased early morbidity.
We evaluated 1,697 consecutive patients undergoing BITA (n = 867) or SITA (n = 830) revascularization. We used propensity score analyses and adjusted risk models to address differences between arms.
There were 20 (2.3%) deaths in the BITA group versus 26 (3.1%) in the SITA group (odds ratio 0.73, p = 0.30). Propensity analysis identified several parameters that affected the decision to use BITA. Adjusting for propensity score and all potential risk factors, the odds ratio for death with BITA versus SITA was practically 1. Bilateral internal thoracic artery revascularization did not increase the number of in-hospital complications with the possible exception of deep sternal wound infections (11 [1.3%] vs. 3 [0.4%], p = 0.057). In multivariate modeling BITA increased the risk of deep sternal wound infections only in emergent cases and in older patients; the excess risk was negligible among 1,206 patients (71.1% of total) who did not have emergent revascularization and were < or =70 years old (risk difference 0.3%, p = 0.74). There was no difference in length of stay after adjustment for propensity factors (mean 11.3 vs. 11.7 days, p = 0.66).
Bilateral internal thoracic artery revascularization grafting confers no increased risk for early death and does not prolong hospital stay. The small increase in the risk of deep sternal wound infections does not affect the majority of patients.
我们研究了与单支胸廓内动脉(SITA)血运重建相比,双侧胸廓内动脉(BITA)血运重建是否会增加住院死亡率及并发症。
尽管已证实BITA血运重建具有长期益处,但由于担心早期发病率增加,其应用进展缓慢。
我们评估了1697例连续接受BITA(n = 867)或SITA(n = 830)血运重建的患者。我们使用倾向评分分析和调整后的风险模型来处理两组之间的差异。
BITA组有20例(2.3%)死亡,SITA组有26例(3.1%)死亡(比值比0.73,p = 0.30)。倾向分析确定了几个影响使用BITA决策的参数。在调整倾向评分和所有潜在风险因素后,BITA与SITA相比的死亡比值比实际上为1。双侧胸廓内动脉血运重建除了可能增加深部胸骨伤口感染外,并未增加住院并发症的数量(11例[1.3%]对3例[0.4%],p = 0.057)。在多变量模型中,BITA仅在急诊病例和老年患者中增加深部胸骨伤口感染的风险;在1206例(占总数的71.1%)未进行急诊血运重建且年龄≤70岁的患者中,额外风险可忽略不计(风险差异0.3%,p = 0.74)。在调整倾向因素后,住院时间没有差异(平均11.3天对11.7天,p = 0.66)。
双侧胸廓内动脉血运重建移植不会增加早期死亡风险,也不会延长住院时间。深部胸骨伤口感染风险的小幅增加不会影响大多数患者。